RXi Pharmaceuticals Corporation Appoints Dr. James Griffin to Scientific Advisory Board
February 14, 2017 at 07:02 am EST
RXi Pharmaceuticals Corporation announced the appointment of James D. Griffin, MD, Chairman, Department of Medical Oncology, Dana-Farber Cancer Institute, to its Scientific Advisory Board. Dr. Griffin also serves as Professor, Medicine, Harvard Medical School and Director, Medical Oncology, Brigham and Women's Hospital. From 1993 to 1998, Dr. Griffin was editor-in-chief of Blood. He is a professor of Medicine at Harvard Medical School and currently sits on the scientific advisory boards of the Lombardi Cancer Center at Georgetown University and the Johns Hopkins Cancer Center and Case Western Cancer Center.